• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiologists' approach to managing cardiovascular risk in patients with type 2 diabetes.

作者信息

Rocha Natalia, Das Sandeep R

机构信息

Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas.

出版信息

J Diabetes. 2019 Jul;11(7):605-609. doi: 10.1111/1753-0407.12918. Epub 2019 May 1.

DOI:10.1111/1753-0407.12918
PMID:31044534
Abstract
摘要

相似文献

1
Cardiologists' approach to managing cardiovascular risk in patients with type 2 diabetes.
J Diabetes. 2019 Jul;11(7):605-609. doi: 10.1111/1753-0407.12918. Epub 2019 May 1.
2
Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists.心脏病专家开具胰高血糖素样肽-1受体激动剂的处方情况。
J Am Coll Cardiol. 2019 Apr 2;73(12):1596-1598. doi: 10.1016/j.jacc.2019.01.029.
3
Which person with diabetes should receive cardioprotective glucose-lowering medicines?哪些糖尿病患者应使用具有心脏保护作用的降糖药物？
J Diabetes. 2020 May;12(5):352-353. doi: 10.1111/1753-0407.13029.
4
Cardiologists' and nephrologists' management of atrial fibrillation in hemodialysis patients
.心脏病专家和肾病专家对血液透析患者心房颤动的管理
Clin Nephrol. 2019 Nov;92(5):226-232. doi: 10.5414/CN109724.
5
Prescribing diabetes medication for cardiovascular risk reduction in patients admitted with acute coronary syndromes: a survey of cardiologists' attitudes and practice.为急性冠状动脉综合征患者开具降糖药物以降低心血管风险：心脏病专家的态度与实践调查
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(3):194-196. doi: 10.1093/ehjcvp/pvz058.
6
SGLT2 inhibitors: practical considerations and recommendations for cardiologists.钠-葡萄糖协同转运蛋白 2 抑制剂：心内科医生的实用考虑和建议。
Curr Opin Cardiol. 2018 Nov;33(6):676-682. doi: 10.1097/HCO.0000000000000561.
7
Are We Ready to Bell The Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes.我们准备好挑战难题了吗？呼吁心脏病专家采用已证实能改善心血管结局的降糖疗法。
Circulation. 2018 Jul 3;138(1):4-6. doi: 10.1161/CIRCULATIONAHA.117.022680.
8
CANadian CAnagliflozin REgistry: Patient-Reported Outcomes of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Canadian Clinical Practice.CANadian CAnagliflozin REgistry：加拿大卡格列净登记研究：卡格列净治疗加拿大临床实践中 2 型糖尿病患者的患者报告结局。
Can J Diabetes. 2019 Oct;43(7):464-471. doi: 10.1016/j.jcjd.2019.04.004. Epub 2019 Apr 16.
9
Interventional cardiology practice: A report of interventional cardiology practice from an extensive survey was presented at EuroPCR 2018.
Eur Heart J. 2019 Jan 14;40(3):234-235. doi: 10.1093/eurheartj/ehy831.
10
Should sodium-glucose co-transporter-2 inhibitors be considered as first-line oral therapy for people with type 2 diabetes?钠-葡萄糖协同转运蛋白2抑制剂是否应被视为2型糖尿病患者的一线口服治疗药物？
Diabetes Obes Metab. 2019 Feb;21(2):207-209. doi: 10.1111/dom.13518. Epub 2018 Oct 3.